Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
23.15
-0.49 (-2.07%)
May 8, 2026, 4:00 PM EDT - Market closed
Pacira BioSciences Market Cap
Pacira BioSciences has a market cap or net worth of $910.9 million as of May 8, 2026. Its market cap has decreased by -24.29% in one year.
Market Cap
910.90M
Enterprise Value
1.12B
1-Year Change
-24.29%
Ranking
Category
Stock Price
$23.15
Market Cap Chart
Since February 3, 2011, Pacira BioSciences's market cap has increased from $121.00M to $910.90M, an increase of 652.81%. That is a compound annual growth rate of 14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 910.90M | -18.19% |
| Dec 31, 2025 | 1.11B | 27.99% |
| Dec 31, 2024 | 869.90M | -44.48% |
| Dec 29, 2023 | 1.57B | -11.56% |
| Dec 30, 2022 | 1.77B | -33.90% |
| Dec 31, 2021 | 2.68B | 3.10% |
| Dec 31, 2020 | 2.60B | 37.52% |
| Dec 31, 2019 | 1.89B | 6.88% |
| Dec 31, 2018 | 1.77B | -4.50% |
| Dec 29, 2017 | 1.85B | 53.30% |
| Dec 30, 2016 | 1.21B | -57.20% |
| Dec 31, 2015 | 2.82B | -11.70% |
| Dec 31, 2014 | 3.20B | 65.79% |
| Dec 31, 2013 | 1.93B | 239.05% |
| Dec 31, 2012 | 568.70M | 281.68% |
| Dec 30, 2011 | 149.00M | 23.14% |
| Feb 3, 2011 | 121.00M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.22B |
| Xeris Biopharma Holdings | 1.13B |
| Evotec SE | 1.08B |
| Alvotech | 1.02B |
| Cronos Group | 971.11M |
| Amphastar Pharmaceuticals | 837.77M |
| Eton Pharmaceuticals | 811.22M |
| Esperion Therapeutics | 808.25M |